• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管斑块的程度可预测系统性红斑狼疮患者的未来心血管事件。

Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.

机构信息

Centre for Rheumatology Research, Division of Medicine, University College London.

Vascular Screening and Diagnostic Centre, London, UK.

出版信息

Rheumatology (Oxford). 2022 Dec 23;62(1):225-233. doi: 10.1093/rheumatology/keac259.

DOI:10.1093/rheumatology/keac259
PMID:35482484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9788823/
Abstract

OBJECTIVE

Patients with SLE have increased prevalence of clinical cardiovascular disease (CVD) and subclinical atherosclerosis. Although 30-40% of patients with SLE have vascular plaque on ultrasound scanning, this study is the first to consider the relationship between total burden of plaque and subsequent CVD risk.

METHODS

One hundred patients with SLE and without any previous clinical CVD underwent vascular ultrasound scans of both carotid and both common femoral bifurcations between 2011 and 2013. Clinical, serological, demographic and treatment data were collected at baseline. Patients were followed till 2020 to identify those who developed new onset coronary disease or stroke. Statistical analysis to identify factors associated with increased risk of developing CVD events was carried out.

RESULTS

Thirty-six patients had plaque at baseline. During follow-up five patients (all had baseline plaque) developed coronary disease and two, without baseline plaque, developed lacunar strokes. Mean (s.d.) age of these patients was 46.5 (4.5) years. Patients with three or more baseline bifurcations with plaque were 10 times more likely to develop CVD than those with 0-2 bifurcations with plaques (OR 9.9, P = 0.009). TPA > 16mm2 was associated with six-fold increased risk of CVD (OR = 6.44, P = 0.028). Patients with disease duration > 14 years were more likely than those with disease duration < 14 years to develop CVD (OR 8.3 P = 0.043).

CONCLUSIONS

The number of bifurcations with plaque and TPA in patients with SLE may be valuable in assessing risk of CVD and deciding on clinical measures to reduce this risk.

摘要

目的

患有 SLE 的患者临床心血管疾病(CVD)和亚临床动脉粥样硬化的患病率增加。尽管 30-40%的 SLE 患者在超声扫描中存在血管斑块,但本研究首次考虑了斑块总负荷与随后 CVD 风险之间的关系。

方法

2011 年至 2013 年间,100 名无任何先前临床 CVD 的 SLE 患者接受了颈动脉和双侧股总分叉处的血管超声扫描。在基线时收集了临床、血清学、人口统计学和治疗数据。随访至 2020 年,以确定那些发生新发冠心病或中风的患者。进行了统计分析以确定与 CVD 事件风险增加相关的因素。

结果

36 名患者在基线时有斑块。在随访期间,有 5 名患者(均有基线斑块)发生了冠心病,2 名无基线斑块的患者发生了腔隙性中风。这些患者的平均(标准差)年龄为 46.5(4.5)岁。基线时有 3 个或更多分叉处有斑块的患者发生 CVD 的可能性是基线时有 0-2 个分叉处有斑块的患者的 10 倍(OR 9.9,P=0.009)。TPA>16mm2 与 CVD 风险增加 6 倍相关(OR=6.44,P=0.028)。疾病持续时间>14 年的患者发生 CVD 的可能性大于疾病持续时间<14 年的患者(OR 8.3,P=0.043)。

结论

SLE 患者分叉处有斑块和 TPA 的数量可能有助于评估 CVD 风险,并决定采取临床措施来降低这种风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efc/9788823/d81653cfacc4/keac259f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efc/9788823/076555e2262b/keac259f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efc/9788823/d81653cfacc4/keac259f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efc/9788823/076555e2262b/keac259f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0efc/9788823/d81653cfacc4/keac259f2.jpg

相似文献

1
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus.血管斑块的程度可预测系统性红斑狼疮患者的未来心血管事件。
Rheumatology (Oxford). 2022 Dec 23;62(1):225-233. doi: 10.1093/rheumatology/keac259.
2
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.总斑块面积和斑块回声强度是系统性红斑狼疮患者亚临床动脉粥样硬化的新指标。
Rheumatology (Oxford). 2021 Sep 1;60(9):4185-4198. doi: 10.1093/rheumatology/keaa905.
3
Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.在系统性硬化症和系统性红斑狼疮中,动脉粥样硬化斑块在无内膜中层增厚的情况下出现:一项关于颈动脉和股动脉的双功超声检查研究及心血管事件随访
Arthritis Res Ther. 2014 Feb 19;16(1):R54. doi: 10.1186/ar4489.
4
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.系统性红斑狼疮中动脉粥样硬化过度:与肾脏受累有关——对281例系统性红斑狼疮患者和281例个体匹配的人群对照的病例对照研究
PLoS One. 2017 Apr 17;12(4):e0174572. doi: 10.1371/journal.pone.0174572. eCollection 2017.
5
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemic lupus erythematosus.传统心血管危险因素控制对系统性红斑狼疮 7 年随访动脉粥样硬化进展的影响。
Rheumatology (Oxford). 2024 Jan 4;63(1):50-57. doi: 10.1093/rheumatology/kead184.
6
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.可溶性 CD163 是系统性红斑狼疮患者发生动脉粥样硬化加速的生物标志物,这些患者的心血管疾病发病风险看似较低。
Scand J Rheumatol. 2020 Jan;49(1):33-37. doi: 10.1080/03009742.2019.1614213. Epub 2019 Jun 4.
7
Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus.系统性红斑狼疮女性患者颈动脉内膜中层厚度及斑块与心血管事件发生的关系。
Am J Cardiol. 2013 Oct 1;112(7):1025-32. doi: 10.1016/j.amjcard.2013.05.040. Epub 2013 Jul 2.
8
The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients.狼疮患者颈动脉粥样硬化与临床缺血性心脏病之间的相关性。
Lupus. 2014 Oct;23(11):1142-8. doi: 10.1177/0961203314537696. Epub 2014 May 29.
9
Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus.丹麦系统性红斑狼疮患者的冠状动脉、颈动脉和下肢动脉粥样硬化及其相互关系
J Rheumatol. 2016 Feb;43(2):315-22. doi: 10.3899/jrheum.150488. Epub 2015 Dec 1.
10
QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus.QRISK3 与颈动脉斑块的相关性高于系统性红斑狼疮患者的评分。
Rheumatology (Oxford). 2022 Apr 11;61(4):1408-1416. doi: 10.1093/rheumatology/keab531.

引用本文的文献

1
Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study.利用代谢组学特征可预测系统性红斑狼疮女性患者的亚临床动脉粥样硬化风险:一项观察性研究
J Am Heart Assoc. 2025 Apr 15;14(8):e036507. doi: 10.1161/JAHA.124.036507. Epub 2025 Apr 7.
2
Vascular damage in systemic lupus erythematosus.系统性红斑狼疮中的血管损伤。
Nat Rev Nephrol. 2024 Apr;20(4):251-265. doi: 10.1038/s41581-023-00797-8. Epub 2024 Jan 3.
3
Carotid total plaque area as an independent predictor of short-term subclinical polyvascular atherosclerosis progression and major adverse cardiac and cerebrovascular events.

本文引用的文献

1
An intensive follow-up in subjects with cardiometabolic high-risk.对存在心血管代谢高危因素的患者进行强化随访。
Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2860-2869. doi: 10.1016/j.numecd.2021.06.011. Epub 2021 Jun 25.
2
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus.一组生物标志物与系统性红斑狼疮女性心血管事件风险增加相关。
ACR Open Rheumatol. 2021 Apr;3(4):209-220. doi: 10.1002/acr2.11223. Epub 2021 Feb 19.
3
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
颈动脉总斑块面积是短期亚临床多血管粥样硬化进展及主要心脑血管不良事件的独立预测因子。
Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231194861. doi: 10.1177/17539447231194861.
4
Accelerated atherosclerosis in systemic lupus erythematosus: don't forget the devil we know!系统性红斑狼疮中的动脉粥样硬化加速:别忘了我们熟知的风险因素!
Rheumatology (Oxford). 2024 Jan 4;63(1):3-5. doi: 10.1093/rheumatology/kead329.
5
Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.通用型和疾病适应型心血管风险评分作为 SLE 患者动脉粥样硬化进展的预测指标。
Lupus Sci Med. 2023 Mar;10(1). doi: 10.1136/lupus-2022-000864.
总斑块面积和斑块回声强度是系统性红斑狼疮患者亚临床动脉粥样硬化的新指标。
Rheumatology (Oxford). 2021 Sep 1;60(9):4185-4198. doi: 10.1093/rheumatology/keaa905.
4
Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.在轻度系统性红斑狼疮(SLE)患者和对照组的 7 年监测中,颈动脉内膜中层厚度的进展相似,但这种进展仍受到血脂异常、较低的高密度脂蛋白(HDL)水平、高血压、狼疮肾炎病史和患者使用较高剂量泼尼松龙的促进。
Lupus Sci Med. 2020 Jan 9;7(1):e000362. doi: 10.1136/lupus-2019-000362. eCollection 2020.
5
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
6
Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors.英国系统性红斑狼疮队列中亚临床和临床心血管疾病的进展:经典因素及与系统性红斑狼疮相关因素的作用
Lupus Sci Med. 2018 Nov 17;5(1):e000267. doi: 10.1136/lupus-2018-000267. eCollection 2018.
7
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.用于估计心血管疾病未来风险的QRISK3风险预测算法的开发与验证:前瞻性队列研究
BMJ. 2017 May 23;357:j2099. doi: 10.1136/bmj.j2099.
8
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.EULAR 建议:类风湿关节炎和其他形式的炎性关节病患者的心血管疾病风险管理:2015/2016 更新。
Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3.
9
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南:欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组(由10个学会的代表和特邀专家组成)由欧洲心血管预防与康复协会(EACPR)特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
10
Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.系统性红斑狼疮患者冠心病风险的最佳监测:一项系统评价
J Rheumatol. 2016 Jan;43(1):54-65. doi: 10.3899/jrheum.150460. Epub 2015 Nov 15.